Innovative drug firms to call for practical support

The country’s forty-one innovative drug makers have plans to ask for the government’s more practical and realistic support for the development of new drugs from next year, according to the Korea Pharmaceutical Manufacturers Association (KPMA).

Previously, these firms set up its three subcommittees to actively foster slew of R&D resources and promote open innovation to make their fruitful out...